This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: University of Leeds. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ian Yule: Innovator in Anticoagulant Research
Introduction
Ian Yule is a notable inventor based in Leeds, GB. He has made significant contributions to the field of anticoagulant research. His work focuses on developing compounds that can inhibit Factor XIIa, which plays a crucial role in blood coagulation.
Latest Patents
Ian Yule holds a patent for Factor XIIA inhibitors. This invention relates to compounds of formula (I) and methods of treatment using these compounds. The compounds are designed to be modulators of Factor XII, specifically targeting Factor XIIa. They may serve as effective anticoagulants, providing new avenues for treatment in patients at risk of thrombotic events.
Career Highlights
Ian Yule is affiliated with the University of Leeds, where he conducts his research. His work has garnered attention for its potential impact on medical treatments related to blood coagulation disorders. He has successfully developed a patent that showcases his innovative approach to addressing these health issues.
Collaborations
Ian collaborates with esteemed colleagues such as Helen Philippou and Richard James Foster. Their combined expertise enhances the research and development of new therapeutic strategies in the field of anticoagulants.
Conclusion
Ian Yule's contributions to the development of Factor XIIA inhibitors highlight his role as an innovator in the medical field. His work at the University of Leeds continues to pave the way for advancements in anticoagulant therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile